Factors affecting transfusion of fresh frozen plasma, platelets, and red blood cells during elective coronary artery bypass graft surgery

Archives of Pathology and Laboratory Medicine

Volumn 127, Issue 4, 2003, Pages 415-423

  Covin, Randal ^a   O'Brien, Maureen ^b   Grunwald, Gary ^a   Brimhall, Bradley ^a   Sethi, Gulshan ^c   Walczak, Steven ^d   Reiquam, William ^a   Rajagopalan, Chitra ^a   Shroyer, A Laurie ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c UNIVERSITY OF ARIZONA   (United States)

^d UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FRESH FROZEN PLASMA;

ADULT; AGED; ARTICLE; BLOOD BANK; BLOOD COMPONENT THERAPY; CORONARY ARTERY BYPASS GRAFT; ERYTHROCYTE TRANSFUSION; FEMALE; HEMOGLOBIN ANALYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PLASMA TRANSFUSION; PREDICTION; PREOPERATIVE EVALUATION; RISK FACTOR; SURGICAL RISK; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION;

BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; CORONARY ARTERY BYPASS; ERYTHROCYTE TRANSFUSION; FEMALE; HOSPITALS, VETERANS; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PLASMA; PLATELET TRANSFUSION; PREDICTIVE VALUE OF TESTS; PREOPERATIVE CARE; RISK FACTORS; SURGICAL PROCEDURES, ELECTIVE;

EID: 0037393367     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Goodnough LT, Johnston MF, Toy PT. The variability of transfusion practice in coronary artery bypass surgery. JAMA. 1991;265:86-90.
2. Hasley PB, Lave JR, Hanusa BH, et al. Variation in the use of red blood cell transfusions: a study of four common medical and surgical procedures. MedCare. 1995;11:1145-1160.
3. Surgenor DM, Churchill WH, Wallace EL, et al. Determinants of red cell, platelet, plasma, and cryoprecipitate transfusions during coronary artery bypass graft surgery: the Collaborative Hospital Transfusion Study. Transfusion. 1996;36: 521-532.
4. Stover EP, Siegel LC, Parks R, et al. Variability in transfusion practice for coronary artery bypass surgery persists despite national consensus guidelines: a 24-institution study. Anesthesiology. 1998;88:327-333.
5. Surgenor DM, Churchill WH, Wallace EL, et al. The specific hospital significantly affects red cell and component transfusion practice in coronary artery bypass graft surgery: a study of five hospitals. Transfusion. 1998;38:122-134.
6. Bracey AW, Radovacevic R. The hematologic effects of cardiopulmonary bypass and the use of hemotherapy in coronary artery bypass grafting. Arch Pathol Lab Med. 1993;118:411-416.
7. S-plus 2000. Guide to statistics. Available at: http://www.insightful.com/support/documentation.asp?did=1. Accessed 2000.
8. Azola C, Harrell FE. An introduction to S-plus and the HMISC and DESIGN libraries. Available at. http://hesweb1.med.virginia.edu/biostat/s/doc/splus.pdf. Accessed 2001.
9. Hosmer DW, Lemeshow S. Applied Logistic Regression. New York, NY: John Wiley and Sons; 1989.
10. Harrell FE, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996;15:361-387.
11. Despotis GJ, Filos KS, Zoys TN, Hogue CW, Spitznagel E, Lappas DG. Factors associated with excessive postoperative blood loss and hemostatic transfusion requirements: a multivariate analysis in cardiac surgical patients. Anesth Analg. 1996;82:13-21.
12. Ferraris VA, Gildengorin V. Predictors of excessive blood use after coronary artery bypass grafting: a multivariate analysis. J Thorac Cardiovasc Surg. 1989;98: 492-497.
13. Ferraris VA, Ferraris SP. Limiting excessive postoperative blood transfusion after cardiac procedures: a review. Texas Heart Inst J. 1995;22:216-230.
14. Cooley DA. Conservation of blood during cardiovascular surgery. Am J Surg. 1995;170:53S-59S.
15. Janssens M, Hartstein G, David J. Reduction in requirements for allogeneic blood products: pharmacologic methods. Ann Thorac Surg. 1996;62:1944-1950.
16. Hardy J-F, Belisle S, Janvier G, Samama M. Reduction in requirements for allogeneic blood products: nonpharmacologic methods, Ann Thorac Surg. 1996; 62:1935-1943.
17. Cosgrove DM, Loop FD, Lytle BW, et al. Determinants of blood utilization during myocardial revascularization. Ann Thorac Surg. 1985;40:380-384.
18. Scott WJ, Rode R, Castlemain B, et al. Efficacy, complications, and cost of a comprehensive blood conservation program for cardiac operations. J Thorac Cardiovasc Surg. 1992;5:1001-1007.
19. Paone G, Spencer T, Silverman NA. Blood conservation in coronary artery surgery. Surgery. 1994;116:672-678.
20. Magovern JA, Sakert T, Benckart DH, et al. A model for predicting transfusion after coronary artery bypass grafting. Ann Thorac Surg. 1996;61:27-32.
21. Rosengart TK, Helm RE, DeBois WJ, Garcia N, Krieger KH, Isom OW. Open heart operations without transfusion using a multimodality blood conservation strategy in 50 Jehovah's Witness patients: implications for a "bloodless" surgical technique. J Am Coll Surg. 1997; 184:618-629.
22. Helm RE, Rosengart TK, Gomez M, et al. Comprehensive multimodality blood conservation: 100 consecutive CABG operations without transfusion. Ann Thorac Surg. 1998;65:125-136.
23. Shevde K, Pagala M, Kashikar A, et al. Gender is an essential determinant of blood transfusion in patients undergoing coronary artery bypass graft procedure. J Clin Anesth. 2000;12:109-116.
24. Bilfinger TV, Conti VR. Blood conservation in coronary artery bypass surgery: prediction with assistance of a computer model. Thorac Cardiovasc Surg. 1989;37:365-368.
25. Anderson RJ, O'Brien M, Whinney SM, et al. Renal failure predisposes patients to adverse outcome after coronary artery bypass surgery. Kidney Int. 1999;55:1057-1062.
26. Ferraris VA, Ferraris SP, Lough FC, Berry WR. Preoperative aspirin ingestion increases operative blood loss after coronary artery bypass grafting. Ann Thorac Surg. 1988;45:71-74.
27. Sethi GK, Copeland JG, Goldman S, Moritz T, Zadina K, Henderson WG. Implications of preoperative administration of aspirin in patients undergoing coronary artery bypass grafting. Department of Veterans Affairs Cooperative Study on Antiplatelet Therapy. J Am Coll Cardiol. 1990;15:15-20.
28. Taggart DP, Siddiqui A, Wheatley DJ. Low-dose preoperative aspirin therapy, postoperative blood loss, and transfusion requirements. Ann Thorac Surg. 1990;50:424-428.
29. Bashein G, Nessly ML, Rice AL, Counts RB, Misbach GA. Preoperative aspirin therapy and reoperation for bleeding after coronary artery bypass surgery. Ann Intern Med. 1991;151:89-93.
30. Rawitscher RE, Jones JW, McCoy TA, Lindsley DA. A prospective study of aspirin's effect on red blood cell loss in cardiac surgery. J Cardiovasc Surg. 1991; 32:1-7.
31. Reich DL, Patel GC, Vela-Cantos F, Bodian C, Lansman S. Aspirin does not increase homologous blood requirements in elective coronary bypass surgery. Anesth Analg. 1994;79:4-8.
32. Tuman KJ, McCarthy RJ, O'Connor CJ, Ivankovich AD. Aspirin does not increase allogeneic blood transfusion in reoperative coronary artery surgery. Anesth Analg. 1996;83:1178-1184.